Literature DB >> 27305204

Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.

Lynn C Hartmann, Noralane M Lindor.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27305204     DOI： 10.1056/NEJMc1602861

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.

Authors:  Lisa Jeffers; Joanne Reid; Donna Fitzsimons; Patrick J Morrison; Martin Dempster
Journal:  Cochrane Database Syst Rev       Date:  2019-10-09

Review 2.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24

3.  Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.

Authors:  Martin P Nilsson; Erik D Nilsson; Barbro Silfverberg; Åke Borg; Niklas Loman
Journal:  Genet Med       Date:  2018-06-06       Impact factor: 8.822

4.  Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study).

Authors:  Camilla Nero; Francesca Ciccarone; Luca Boldrini; Jacopo Lenkowicz; Ida Paris; Ettore Domenico Capoluongo; Antonia Carla Testa; Anna Fagotti; Vincenzo Valentini; Giovanni Scambia
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.